Literature DB >> 21761359

Microenvironment and pathogenesis of epithelial ovarian cancer.

Antonio F Saad1, Wei Hu, Anil K Sood.   

Abstract

Multiple genetic alterations play a role in the pathogenesis of ovarian cancer. Although many key proteins and pathways involved in ovarian carcinogenesis and metastasis have been discovered, knowledge of the early steps leading to malignancy remains poorly understood. This poor understanding stems from lack of data from early-stage cancers and absence of a well-established premalignant state universal to all ovarian cancer subtypes. Existing evidence suggests that ovarian cancers develop either through a stepwise mutation process (low-grade pathway), through genetic instability resulting in hastened metastasis (high-grade pathway), or more recently through what has been described as the "'fimbrial-ovarian' serous neoplasia theory." In this latter model, ovarian serous cancers evolve from premalignant lesions in the distal fallopian tube called tubal intraepithelial carcinoma. In this manuscript, we review key genetic and molecular changes that occur in cancer cell progression and suggest a model of ovarian cancer pathogenesis involving both tumor cell mutations and microenvironmental factors. © Springer Science+Business Media, LLC 2010

Entities:  

Mesh:

Year:  2010        PMID: 21761359      PMCID: PMC3199131          DOI: 10.1007/s12672-010-0054-2

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  151 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.

Authors:  Brian C Cooper; Justine M Ritchie; Carrie L W Broghammer; Jeremy Coffin; Joel I Sorosky; Richard E Buller; Mary J C Hendrix; Anil K Sood
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

3.  Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.

Authors:  Liz Y Han; Charles N Landen; Jose G Trevino; Jyotsnabaran Halder; Yvonne G Lin; Aparna A Kamat; Tae-Jin Kim; William M Merritt; Robert L Coleman; David M Gershenson; William C Shakespeare; Yihan Wang; Raji Sundaramoorth; Chester A Metcalf; David C Dalgarno; Tomi K Sawyer; Gary E Gallick; Anil K Sood
Journal:  Cancer Res       Date:  2006-09-01       Impact factor: 12.701

4.  Apoptosis and apoptosis-related proteins (Fas, Fas ligand, Blc-2, p53) in lymphoid elements of human ovarian tumors.

Authors:  H Ben-Hur; P Gurevich; M Huszar; A Ben-Arie; V Berman; Y Tendler; O Zinder; R Tchanishev; S Gershon; G Mor; Y Zaltsman; F Kohen; I Zusman
Journal:  Eur J Gynaecol Oncol       Date:  2000       Impact factor: 0.196

5.  An abundance of p53 null mutations in ovarian carcinoma.

Authors:  J S Skilling; A Sood; T Niemann; D J Lager; R E Buller
Journal:  Oncogene       Date:  1996-07-04       Impact factor: 9.867

6.  Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.

Authors:  M K Dodson; L C Hartmann; W A Cliby; K A DeLacey; G L Keeney; S R Ritland; J Q Su; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

7.  Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

Authors:  S D Merajver; T M Pham; R F Caduff; M Chen; E L Poy; K A Cooney; B L Weber; F S Collins; C Johnston; T S Frank
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

8.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

9.  p53 gene mutations and protein accumulation in human ovarian cancer.

Authors:  J Kupryjańczyk; A D Thor; R Beauchamp; V Merritt; S M Edgerton; D A Bell; D W Yandell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

10.  Ovarian tumors of the hen.

Authors:  T N Fredrickson
Journal:  Environ Health Perspect       Date:  1987-08       Impact factor: 9.031

View more
  35 in total

Review 1.  PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

2.  The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis.

Authors:  Courtney A Cohen; Amanda A Shea; C Lynn Heffron; Eva M Schmelz; Paul C Roberts
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-10

3.  Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development.

Authors:  Allen Mo; Stephen Jackson; Kamini Varma; Alan Carpino; Charles Giardina; Thomas J Devers; Daniel W Rosenberg
Journal:  Mol Cancer Res       Date:  2016-06-27       Impact factor: 5.852

4.  New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research.

Authors:  Mark E Sherman; Richard Guido; Nicolas Wentzensen; Hannah P Yang; Phuong L Mai; Mark H Greene
Journal:  Gynecol Oncol       Date:  2012-08-29       Impact factor: 5.482

5.  Identification of epithelial ovarian tumor-specific aptamers.

Authors:  Gregory Benedetto; Timothy J Hamp; Peter J Wesselman; Christine Richardson
Journal:  Nucleic Acid Ther       Date:  2015-04-20       Impact factor: 5.486

6.  Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.

Authors:  Christine Gruessner; Angelika Gruessner; Katherine Glaser; Nisreen Abushahin; Cynthia Laughren; Wenxin Zheng; Setsuko K Chambers
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

7.  Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer.

Authors:  Cristina Ivan; Wei Hu; Justin Bottsford-Miller; Behrouz Zand; Heather J Dalton; Tao Liu; Jie Huang; Alpa M Nick; Gabriel Lopez-Berestein; Robert L Coleman; Keith A Baggerly; Anil K Sood
Journal:  Gynecol Oncol       Date:  2012-11-28       Impact factor: 5.482

8.  Notch3 pathway alterations in ovarian cancer.

Authors:  Wei Hu; Tao Liu; Cristina Ivan; Yunjie Sun; Jie Huang; Lingegowda S Mangala; Takahito Miyake; Heather J Dalton; Sunila Pradeep; Rajesh Rupaimoole; Rebecca A Previs; Hee Dong Han; Justin Bottsford-Miller; Behrouz Zand; Yu Kang; Chad V Pecot; Alpa M Nick; Sherry Y Wu; Ju-Seog Lee; Vasudha Sehgal; Prahlad Ram; Jinsong Liu; Susan L Tucker; Gabriel Lopez-Berestein; Keith A Baggerly; Robert L Coleman; Anil K Sood
Journal:  Cancer Res       Date:  2014-04-17       Impact factor: 12.701

9.  Alteration of microRNA profiling in sphere-cultured ovarian carcinoma cells.

Authors:  Hwa Jun Cha; Sung Kwan An; Tae Jin Kim; Jae Ho Lee
Journal:  Oncol Lett       Date:  2018-05-25       Impact factor: 2.967

10.  Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation.

Authors:  Zhenqiu Liu; Jessica A Beach; Hasmik Agadjanian; Dongyu Jia; Paul-Joseph Aspuria; Beth Y Karlan; Sandra Orsulic
Journal:  Gynecol Oncol       Date:  2015-09-06       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.